Quick Answer
Trevi Therapeutics, Inc. reported Total Assets of $193.44 million for fiscal year 2025.
Trevi Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $193.44M | +74.4% |
| 2024 | $110.90M | +24.0% |
| 2023 | $89.40M | -27.3% |
| 2022 | $123.02M | +219.7% |
| 2021 | $38.48M | -18.4% |
| 2020 | $47.13M | -21.4% |
| 2019 | $60.00M | +470.0% |
| 2018 | $10.53M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $199.36M | +189.3% | -4.3% |
| June 30, 2025 | $208.34M | +182.3% | +94.7% |
| March 31, 2025 | $107.00M | +36.2% | -3.5% |
| December 31, 2024 | $110.90M | +24.0% | +60.9% |
| September 30, 2024 | $68.91M | -28.1% | -6.6% |
| June 30, 2024 | $73.81M | -26.9% | -6.0% |
| March 31, 2024 | $78.56M | -32.4% | -12.1% |
| December 31, 2023 | $89.40M | -27.3% | -6.8% |
- Trevi Therapeutics, Inc. showed an increase of +74.4% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Trevi Therapeutics, Inc.’s total assets has grown by 1737.7% (from $10.53 million to $193.44 million).
- The most recent figure is from Trevi Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: